What is the current Spasticity Treatment Market size?

The Spasticity Treatment Market is projected to register a CAGR of 10.10% during the forecast period (2024-2029) Read More

Who are the key players in Spasticity Treatment Market?

Medtronic Plc, Piramal Enterprises Ltd, Allergan plc, Ipsen and F. Hoffmann-La Roche Ltd are the major companies operating in the Spasticity Treatment Market. Read More

Which is the fastest growing region in Spasticity Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Spasticity Treatment Market?

In 2024, the North America accounts for the largest market share in Spasticity Treatment Market. Read More

What years does this Spasticity Treatment Market cover?

The report covers the Spasticity Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Spasticity Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Spasticity Drugs Market Size & Share Analysis - Industry Research Report

Spasticity Drugs Industry Overview

The spasticity Treatment market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominating the market are developing new products to address unmet challenges in the market. In January 2020, Ipsen received approval for Dysport by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA). The Dysport is a clostridium botulinum type A toxin-haemagglutinin complex is used for the symptomatic treatment of focal spasticity of upper limbs in children with cerebral palsy. The product was earlier approved in major geographies including United States, the recent approval for the sales in UK is expected to have a positive impact on the global market growth. Some of the companies which are currently dominating the market are Medtronic Plc, Piramal Enterprises Ltd, Allergan plc, Ipsen, and F. Hoffmann-La Roche Ltd.